GALWAY, IRELAND--March 5, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--One of Japan's leading pharmaceutical companies, Daiichi Sankyo Propharma Company Limited has unveiled a 1 billion euro (US$1.09 billion) investment to expand its drug making operations in Germany. Within this article: Details investment, timeline, company's push into cancer treatment sector, leading drugs in development, major deals with other players.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
